Enhanced iPSC Cardiomyocyte Maturation via Combined 3D-Culture and Metabolic Cues

R. Sabine (Würzburg)1, H. Eberl (Würzburg)1, N. Wagensohner (Würzburg)1, N. Dybkova (Göttingen)2, J. Unsöld (Würzburg)1, J. Dudek (Würzburg)3, P. Costa (Freiburg im Breisgau)4, M. Fernandez (Freiburg im Breisgau)4, E. Rog-Zielinska (Freiburg im Breisgau)5, F. Schneider-Warme (Freiburg im Breisgau)5, C. Maack (Würzburg)3, S. T. Sossalla (Gießen)6, K. Streckfuß-Bömeke (Würzburg)7
1Julius-Maximilians-Universität Würzburg Pharmakologisches Institut Würzburg, Deutschland; 2Universitätsmedizin Göttingen Herzzentrum, Klinik für Kardiologie und Pneumologie Göttingen, Deutschland; 3Universitätsklinikum Würzburg Deutsches Zentrum für Herzinsuffizienz/DZHI Würzburg, Deutschland; 4Albert- Ludwigs-Universität Freiburg Freiburg im Breisgau, Deutschland; 5Universitäts-Herzzentrum Freiburg - Bad Krozingen Institut für Experimentelle Kardiovaskuläre Medizin Freiburg im Breisgau, Deutschland; 6Universitätsklinikum Gießen und Marburg GmbH Medizinische Klinik I - Kardiologie und Angiologie Gießen, Deutschland; 7Universitätsklinikum Würzburg Institut für Pharmakologie und Toxikologie Würzburg, Deutschland

Induced pluripotent stem-cells (iPSC) and their subsequent differentiation into cardiomyocytes (CM) and other cardiac-relevant cell types became an invaluable tool in cardiovascular research. Many etiologies of heart failure involve defects in excitation-contraction coupling, mitochondrial energetics or both, but currently available iPSC-CM are limited by the developmental immaturity in respect to these processes. Maturation strategies typically include long-term culture, fatty-acid enriched medium, or mechanical or electrical stimulation. We aim to boost maturation by a novel combinatorial approach of 3D-spheroid culture with a specially composed maturation medium (MM). This MM is composed of three fatty-acids, hormones, and a PPARα-agonist. To evaluate the maturation progress, we analyzed 2D-cultures and 3D-spheroids via molecular and functional read outs including adult CM isoform-switches on mRNA-level via qPCR, sarcomeric and mitochondrial structures via immunostaining, single-cell patch clamp recordings for action potentials, Ca2+ homeostasis with Indo-1-probe imaging, the mitochondrial membrane-potential (ΔΨM) with the TMRM-probe and the mitochondrial Ca2+ content with imaging genetically-encoded Pericam.

This systematic investigation demonstrates that the spheroid+MM protocol produces iPSC-CM with adult-like features yielding rod-shaped cells with the appropriate sarcomeric length, refined action potential shape and parameters concomitant with higher systolic Ca2+ levels, and a high sensitivity to β-adrenergic stimulation. In contrast, the mitochondrial arrangement is not improved, however the mitochondrial function is enhanced, which is demonstrated by higher ΔΨM and mitochondrial Ca2+ levels. To test the assumption that disease traits can be unmasked by enhanced maturation, we investigated the splice-defect in patient-iPSC-CM with a mutation in the splicing factor RBM20. We demonstrated more pronounced mis-splicing of RBM20 target genes CAMK2D and triadin in RBM20-CM vs isogenic rescue-CM cultured as spheroid+MM compared to their long-term culture cohort. Taken together, we present a maturation approach that significantly enhances structural, metabolic and functional parameters and can unmask disease traits in genetically caused cardiomyopathies.